Rosen, respected investor counsel, encourages cortexyme, inc. investors with losses to inquire about securities class action investigation – crtx

New york--(business wire)-- #crtx--why: rosen law firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of cortexyme, inc. (nasdaq: crtx) resulting from allegations that cortexyme may have issued materially misleading business information to the investing public. so what: if you purchased cortexyme securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement
QNCX Ratings Summary
QNCX Quant Ranking